Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year (Q45770297)
scientific article published in July 1996
Language:
Current Data About Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year
(P31) (Q13442814)
(P248)
(P698) 8655994
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/8655994

(P50) (Q90899786)
(P1545) 2

(P304) 195-198
(P248)
(P698) 8655994
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/8655994

(P407) (Q1860)

(P433) 1
(P248)
(P698) 8655994
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/8655994

(P478) 174
(P248)
(P698) 8655994
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/8655994

(P577) Monday, July 1, 1996
(P248)
(P698) 8655994
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/8655994

(P921) (Q12199)
(P1810) Acquired Immunodeficiency Syndrome
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/8655994

(Q40207875)
(P1810) antiviral agents
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/8655994

(Q18907320)
(P1810) HIV-1
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/8655994

(Q198504)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/8655994

(P1433) (Q4051141)
(P248)
(P698) 8655994
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/8655994

(P1476) "Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year. Sydney Primary HIV Infection Study Group" (language: en)
(P248)
(P698) 8655994
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/8655994

(P2093) Imrie A
(P1545) 1
(P248)
(P698) 8655994
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/8655994

Duncombe C
(P1545) 3
(P248)
(P698) 8655994
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/8655994

Finlayson R
(P1545) 4
(P248)
(P698) 8655994
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/8655994

Vizzard J
(P1545) 5
(P248)
(P698) 8655994
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/8655994

Law M
(P1545) 6
(P248)
(P698) 8655994
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/8655994

Kaldor J
(P1545) 7
(P248)
(P698) 8655994
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/8655994

Penny R
(P1545) 8
(P248)
(P698) 8655994
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/8655994

Cooper DA
(P1545) 9
(P248)
(P698) 8655994
(P813) Friday, December 15, 2017
(P854) http://europepmc.org/abstract/MED/8655994

Sydney Primary HIV Infection Study Group
(P1545) 10

other details
description scientific article published in July 1996

External Links
(P356) 10.1093/INFDIS/174.1.195
(P698) 8655994
(P5875) 14544559